Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
about
Immunohistochemical markers for arthritis in psoriasis.Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanomaFunctional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes.Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes.Overview of psoriasis.Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium.Advances in the management of psoriasis: monoclonal antibody therapies.The role of T cells in psoriasis.Use of common Chinese herbs in the treatment of psoriasis.β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome.Paradoxical exacerbation of psoriasis in AIDS: proposed explanations including the potential roles of substance P and gram-negative bacteria.Psoriasis: emerging therapeutic strategies.Tazarotene: a review of its pharmacological profile and potential for clinical use in psoriasis.Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes.Detection of a gamma interferon-induced protein IP-10 in psoriatic plaquesPUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapyPsoriasis: evolution of pathogenic concepts and new therapies through phases of translational research.Cellular misfolded proteins rescued from degradation by MHC class II molecules are possible targets for autoimmune diseases.A study of local immunity in psoriasis.Modulation of interferon-gamma-induced HLA-DR expression on the human keratinocyte cell line SCC-13 by ultraviolet radiation.Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw60 on normal keratinocytes.1 alpha,25-dihydroxy vitamin D3 modulation of HLA-DR mRNA induced by gamma-interferon in cultured epithelial tumor cell lines.The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium.Effect of propylthiouracil and methimazole on serum levels of interleukin-2 receptors in patients with psoriasis.Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial.Subcutaneously administered efalizumab (anti-CD11a) improves signs and symptoms of moderate to severe plaque psoriasis.
P2860
Q33566463-FCFC8BCE-AB5F-4188-B9EB-4EF5FACC7D1EQ33788644-DA092115-F379-4B29-AA80-5D08CFFDCA73Q34274604-8B408E8A-D340-4038-B6F6-DAFACB575D5EQ34298307-5CC98803-A461-44F3-B05E-8A036E426FD9Q34395938-D362D43D-4FB5-4039-9EC9-6A12E21489C7Q34551058-341A75CE-8C4F-4408-B464-2D65DC4DACF9Q34647617-DF7702F4-84A6-46FD-9EA9-0BB7AFF6BDC2Q35030921-6F31378B-EE2D-48A3-9393-9728DA82E386Q35110104-8A5D4CAA-870D-42DA-9D80-60E008B5EF99Q35209615-E8DCEAA3-F9C0-45FD-B0E1-49A5D7654384Q35584256-AEAAC138-A2A6-47F1-9506-06D0F4D1A5C1Q35759102-CC49E925-486B-4783-8B75-7640C0FE8192Q36028220-AAE23858-7F28-4878-B723-4BF07E063610Q36179670-D518F8E9-6C65-4EDC-B478-A8654CF2AC4EQ36354547-91BD716E-0461-4AAB-B14E-E7E671B04A8EQ36355271-DB2EDEA5-ABF0-4A4B-BD2A-4DA924FCBBCAQ36363445-B29B1EEF-62D4-482D-99B8-77B5EB950A28Q36917184-20CE5EB3-D043-4BAD-89E0-E39C3C8DD04EQ38588610-4BEEEF1F-44F8-49C8-90E8-C0C23A5DF9A3Q41347940-E8413607-3EF6-4279-8942-7EB3C78B0290Q41574829-2A0187BD-A330-4D0F-8598-E329E31DF95EQ42017642-A745E0CB-F2BE-4DE9-B842-6AA50F3256CCQ42502346-AFE968B0-F3C9-419C-BE92-E106D897ACC3Q43456236-C42E3643-9E22-4C09-93A1-12D1DEE4B296Q44390825-41E49C8F-1A99-4AAE-95D9-904D7CC6DE1EQ46539253-EC164021-77DD-4031-9979-8C64CB1E9AA8Q52932186-940F03FD-3902-4E9D-A592-DFF459016252Q53863305-02F3F90A-E2D7-47DE-B973-4E05602B36CF
P2860
Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Expression of HLA-DR molecules ...... e of active psoriatic plaques.
@ast
Expression of HLA-DR molecules ...... e of active psoriatic plaques.
@en
type
label
Expression of HLA-DR molecules ...... e of active psoriatic plaques.
@ast
Expression of HLA-DR molecules ...... e of active psoriatic plaques.
@en
prefLabel
Expression of HLA-DR molecules ...... e of active psoriatic plaques.
@ast
Expression of HLA-DR molecules ...... e of active psoriatic plaques.
@en
P2093
P2860
P356
P1476
Expression of HLA-DR molecules ...... e of active psoriatic plaques.
@en
P2093
A B Gottlieb
B Lifshitz
D M Carter
L Staiano-Coico
P2860
P304
P356
10.1084/JEM.164.4.1013
P407
P577
1986-10-01T00:00:00Z